NextCure, Inc. (NXTC) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$57.62M | +3.6% |
| 2024 | -$59.75M | +11.7% |
| 2023 | -$67.64M | +10.9% |
| 2022 | -$75.91M | -7.3% |
| 2021 | -$70.77M | -71.7% |
| 2020 | -$41.23M | -10.0% |
| 2019 | -$37.48M | -61.6% |
| 2018 | -$23.20M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$57.62M | +3.6% |
| 2024 | -$59.75M | +11.7% |
| 2023 | -$67.64M | +10.9% |
| 2022 | -$75.91M | -7.3% |
| 2021 | -$70.77M | -71.7% |
| 2020 | -$41.23M | -10.0% |
| 2019 | -$37.48M | -61.6% |
| 2018 | -$23.20M | — |